<DOC>
	<DOCNO>NCT01381731</DOCNO>
	<brief_summary>The objective trial : - Assess safety tolerability diquafosol tetrasodium ophthalmic solution versus placebo follow one week treatment subject undergo photorefractive keratectomy ( PRK ) . - Evaluate potential diquafosol accelerate corneal wound healing/re-epithelialization follow PRK .</brief_summary>
	<brief_title>A Double-masked , Randomized , Placebo-controlled , Pilot Study Diquafosol Tetrasodium Subjects Following Photorefractive Keratectomy ( PRK )</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>age 18 45 year old candidate bilateral PRK dry eye disease corneal pathology previous corneal intraocular surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>post PRK wound healing</keyword>
</DOC>